20340 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole; Oxazoles 1,3-Oxazoles, e.g. pemoline, trimethadione
2-PENTADECYL-2-OXAZOLINE IN ASSOCIATION WITH BUTYRIC ACID OR A SALT THEREOF IN THE TREATMENT OF EPILEPSY
#2CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION
#3PPAR-ALPHA/GAMMA AGONIST FOR USE IN THE TREATMENT OF LIVER FAILURE
#4CYCLOPENTANE COMPOUND
#5METHOD OF TREATING NEURODEGENERATIVE DISEASES
#6PHARMACEUTICAL COMBINATION COMPRISING PONESIMOD
#7OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION
#8METHODS FOR REPROGRAMING EXHAUSTED T CELLS AND BOOSTING IMMUNE CHECKPOINT BLOCKADE THERAPY FOR CANCER
#9PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS
#10N-(BENZHYDRYL)CYCLOALKYLCARBOXAMIDE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF
#11INHALATION FORMULATION FOR TREATING IPF DISEASE AND PREPARATION METHOD THEREFOR
#12PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#13Compositions for Modulating Lipoxygenase and Methods of Using Same
#142-PENTADECYL-2-OXAZOLINE AS AN OPIOID ADJUVANT TO PREVENT OR TREAT HYPERALGESIA
#15COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
#16MODULATORS OF EUKARYOTIC INITIATION FACTOR 2B, COMPOSITIONS AND METHODS
#17HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN
#183-ALKYNYL CARBOXAMIDES AS AEP MODULATORS
#19COLLAGEN MACROPEPTIDE PREPARATIONS AND USES THEREOF
#20PHARMACEUTICAL COMPOSITION AND METHODS FOR MODULATING INFLAMMATION AND OXIDATIVE STRESS
#21PHARMACEUTICALLY ACTIVE COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING PENDRIN
#22SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF
#23Synthetic Eicosanoid Analogues for the Treatment and Prevention of Diseases Associated with Increased GDF15 Plasma Concentration
#24Alpha, Beta-UNSATURATED AMIDE COMPOUND, AND PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#25REVERSIBLE LYSINE COVALENT MODIFIERS OF CDK2 AND USES THEREOF
#26PREP BINDING LIGANDS
#27COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME
#28TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
#29AMIDO CYCLOPROPYL DERIVATIVES AS LPA RECEPTOR INHIBITORS
#30THERAPEUTIC COMBINATIONS, COMPOSITIONS, AND METHODS FOR DESIGNING AND PRODUCING ENTACTOGENIC MINDSTATES
#31New Coolants, and Preparations Containing Same
#32THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF
#33ANTI-INFLAMMATORY AND ANALGESIC COMPOUNDS AND USE THEREOF
#34REGULATING MICROTUBULE DYNAMICS AS A THERAPEUTIC TARGET FOR NERVE REPAIR
#35KAT6 Inhibitors
#36METHODS OF TREATING AMYLOID RELATED BRAIN DISORDERS USING NOVEL COMPOUNDS AND ANTIBODIES
#37FORMULATION OF METAXALONE
#38METHODS OF LOWERING BLOOD GLUCOSE AND TREATING TYPE 2 DIABETES BY ACTIVATION OF PDE4D3
#39Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
#40Method for improving the dissolution profile of a biologically active material
#41METHOD FOR PREVENTING AND/OR TREATING LIVER FIBROSIS BY USING 6-METHOXYBENZOXAZOLINONE AND COIX LACHRYMA-JOBI L. EXTRACT COMPRISING 6-METHOXYBENZOXAZOLINONE
#42C5AR INHIBITORS FOR USE IN THE TREATMENT OF CHEMOTHERAPY-INDUCED IATROGENIC PAIN
#43Manufacturing Process for Metaxalone Tablets
#44IMIDAZOLE CONTAINING COMPOUNDS, DERIVATIVES THEREFORE, AND USES THEREOF
#45PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS
#46OINTMENT CONTAINING AN OXAZOLE COMPOUND
#47Hepatitis B Antiviral Agents
#48INHIBITORS OF 12/15-LIPOXYGENASE
#49GASTRORETENTIVE DOSAGE FORMS FOR SUSTAINED DRUG DELIVERY
#50Covalent Inhibitors As Antiviral Agents
#51COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
#52REDUCED DOSE METAXALONE FORMULATIONS
#53PYRAZINE-CONTAINING COMPOUND
#54MODULATORS OF THE INTEGRATED STRESS PATHWAY
#55METHODS AND COMPOSITIONS FOR TREATING CHRONIC LIVER DISEASE AND HEPATOCELLULAR CARCINOMA
#56NOVEL OXAZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES COMPRISING THE SAME
#57NAMPT MODULATORS
#58NLRP3 ACTIVATORS FOR USE IN THE TREATMENT OF INFECTIOUS DISEASES OR CANCER BY ACTIVATING NLRP3 INFLAMMASOME
#59FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF CONDITIONS RELATED TO METABOLIC SYNDROME
#60METHODS OF REDUCING ACNE AND ROSACEA RELAPSE RATE AND SEVERITY
#61Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#622-CARBOXYL-INDOLE INHIBITORS OF METALLO-BETA-LACTAMASES
#63TEAD INHIBITORS
#64METHODS AND COMPOSITIONS FOR INDUCING BROWN ADIPOGENESIS
#65Precision Medicine Approach to Treating Parkinson's Disease with a Monoamine Oxidase Inhibitor, an Antioxidant, or Both
#66STRONG POTENTIATION OF TLR3 AGONISTS EFFECTS USING FXR AGONISTS AS A COMBINED TREATMENT
#67REDUCED DOSE METAXALONE FORMULATIONS
#68METHODS OF TREATING NEUROINFLAMMATION AND INHIBITING MONOAMINE OXIDASE-A AND RESTORING/UPREGULATING/INCREASING IL-13 AND AND PGC-1 BY ADMINISTERING ORAL DOSAGE FORM CONTAINING MICRONIZED AND NONMICRONIZED PARTICULATE METAXALONE, ALGINIC ACID AND PROPYLENE GLYCOL ALGINATE
#69DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC)
#70MODULATORS OF THE INTEGRATED STRESS PATHWAY
#71Use of Chaperone-Mediated Autophagy Activators For Treating Or Preventing Blood Cancers And Myelodysplastic Syndromes And Enriching Hematopoietic Stem Cell Populations
#72COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING FERROPTOSIS AND TREATING EXCITOTOXIC DISORDERS
#73FORMULATION OF METAXALONE
#74OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION
#75AGENT FOR SUPPRESSING IL-31 PRODUCTION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
#76PHARMACEUTICAL COMBINATION COMPRISING PONESIMOD
#77HBV INHIBITOR AND ITS USE
#78THERAPY BASED ON SYNTHETIC LETHALITY IN SWI/SNF COMPLEX-DYSFUNCTION CANCER
#79Gastroretentive dosage forms for sustained drug delivery
#80SUBSTITUTED HETEROARYL COMPOUNDS AND USE THEREOF
#81NOVEL PSYCHEDELIC COMPOSITIONS, DELIVERY SYSTEMS AND THERAPEUTIC USES THEREOF
#82PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#83COMBINATIONS OF 15-PGDH INHIBITORS WITH CORTICOSTEROIDS AND/OR TNF INHIBITORS AND USES THEREOF
#84ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE
#85INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS
#86LIPID NANOPARTICLES AND LIPOSOMES
#87Neprilysin inhibitors
#88Reduced dose metaxalone formulations
#89Pharmaceutical use of (E)-3-arylheterocyclylprop-2-enoic acid derivatives
#90OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT
#91Compositions and methods of treating cardiac fibrosis with ifetroban
#92Hepatitis B antiviral agents
#93HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
#94METHODS AND COMPOSITIONS FOR INDUCING BROWN ADIPOGENESIS
#95COMPOSITIONS AND METHODS FOR ACTIVATING SIGNALING THROUGH THE CB2 CANNABINOID RECEPTOR FOR TREATING AND PREVENTING LYSOSOMAL STORAGE DISEASES AND DISORDERS
#96Method for the Production of Commercial Nanoparticle and Microparticle Powders
#97NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION
#98N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS
#99MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAY
#100COMPOSITION COMPRISING RILMENIDINE COMPOUND AS ACTIVE INGREDIENT FOR TREATMENT OF FRAGILE X SYNDROME OR RELATED DEVELOPMENTAL DISABILITY
#101COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#102METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY
#103Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#104Modulators of eukaryotic initiation factor 2B, compositions and methods
#105Phenyl-sulfamoyl.benzoyc acids as ERAP1 modulators
#106METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS
#107AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF
#108Immunomodulation by IAP Inhibitors
#109TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT
#110Pyrazine-containing compound
#111OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION
#112Composition Comprising at Least One Oxazoline for Inhibiting the Growth of Malassezia Yeasts Involved in Cradle Cap, in Particular
#113FORMULATION OF METAXALONE
#114GASTRORETENTIVE DOSAGE FORMS FOR SUSTAINED DRUG DELIVERY
#115PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS COMPRISING INHIBITORS OF THE ANDROGEN RECEPTOR AND USES THEREOF
#116NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT
#117HBV inhibitor and its use
#118Inhibition of Monoamine Oxidase Subtype A (MAOA) Mitigates Cardiovascular Calcification
#119SOLIDIFICATION OR CRYSTALLISATION METHOD
#120Inhibitors of Bcl-2
#121AGENTS FOR TREATMENT OF ALCOHOL USE DISORDER
#122Synergistically cooperative compositions useful for soft tissue augmentation, drug delivery and related fields
#123OINTMENT CONTAINING AN OXAZOLE COMPOUND
#124Neprilysin inhibitors
#125OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS
#126FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
#127LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST AND PREPARATION METHOD THEREFOR
#128INHIBITORS TO TARGET HIV-1 NEF-CD80/CD86 INTERACTIONS FOR THERAPEUTIC INTERVENTION
#129USE OF INHIBITORS OF PHOSPHATASE ACTIVITY OF SOLUBLE EPOXIDE FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES
#130Pyrazine-containing compound
#131Novel formulation of metaxalone
#132PHARMACEUTICAL COMPOUNDS
#133(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
#134Method for improving the dissolution profile of a biologically active material
#135MODULATORS OF THE INTEGRATED STRESS PATHWAY
#136New use of R-enantiomer of adrenergic beta 2 receptor agonists for treatment of inflammatory bowel disease and its extra intestinal manifestations
#137METHODS OF TREATING DISEASES AND DISORDERS RESULTING FROM BETA CORONAVIRUS INFECTION
#138PROPHYLACTIC OR THERAPEUTIC AGENT FOR PULMONARY HYPERTENSION WHICH COMPRISES PPAR? AGONIST
#139Analogs of CYP-Eicosanoids for Use in Treating or Preventing a Disorder Associated with Neovascularization and/or Inflammation
#140P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same
#141Oxazolidinones as TarO inhibitors
#142HETEROCYCLIC COMPOUND
#143Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
#144AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same
#145COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING FERROPTOSIS AND TREATING EXCITOTOXIC DISORDERS
#146METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY
#147METHODS FOR TREATING OR PREVENTING CARDIOVASCULAR DISORDERS AND LOWERING RISK OF CARDIOVASCULAR EVENTS
#148Methods of treating PACS1 and PACS2 syndromes
#149Hepatitis B antiviral agents
#150Hetero-halo inhibitors of histone deacetylase
#151MODULATORS OF THE INTEGRATED STRESS PATHWAY
#152PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#153Electrospun fibers for a local release of an anti-inflammatory drug and a promyelinating drug
#154Oxazolidinone hydroxamic acid derivatives
#155Fatty acids as anti-inflammatory agents
#156Gastroretentive dosage forms for sustained drug delivery
#157Hepatitis B antiviral agents
#158ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE
#159METHODS OF TREATING NEURODEGENERATIVE DISEASES USING INDANE ACETIC ACID DERIVATIVES WHICH PENETRATE THE BLOOD BRAIN BARRIER
#160Metaxalone formulations
#161Use of prostacyclin antagonists for treating ocular surface nociception
#162TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION
#163TREM2 AGONISTS FOR THE STIMULATION OF MICROGLIA AND METHODS OF IDENTIFICATION
#164Novel class of compounds for the treatment of cardiovascular disease.
#165NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING PROTEINOPATHIES COMPRING THE SAME
#166Methods for preparing stabilized amorphous drug formulations using acoustic fusion
#167Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
#168INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS
#169METHOD OF TREATING FIBROTIC DISEASE
#170FORMULATION OF METAXALONE
#171Compositions and methods for treating severe pain
#172OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS
#173Pyrazine-containing compound
#174Farnesoid X receptor agonists and uses thereof
#175Gastroretentive dosage forms for sustained drug delivery
#176REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#177REDUCED DOSE METAXALONE FORMULATIONS
#178C5aR inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain
#179Method for the Production of Commercial Nanoparticle and Microparticle Powders
#180COMBINED COLLAGEN NSAID ANALGESIC DOSAGE REGIMEN
#181Method for improving the dissolution profile of a biologically active material
#182Pyrazine-containing compound
#183MODULATORS OF THE INTEGRATED STRESS PATHWAY
#184Immunomodulation by IAP inhibitors
#185USE OF PROSTACYCLIN ANTAGONISTS FOR TREATING OCULAR SURFACE NOCICEPTION
#186Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
#187Gastroretentive dosage forms for sustained drug delivery
#188Novel formulation of metaxalone
#189FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF
#190Neprilysin inhibitors
#191(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
#192Oxazolidinones as taro inhibitors
#193Gastroretentive dosage forms for sustained drug delivery
#194Hetero-halo inhibitors of histone deacetylase
#195Chemotherapeutic methods for treating low-proliferative disseminated tumor cells
#196Method of treating or preventing Ras-mediated diseases
#197METHODS FOR TREATING OR PREVENTING CARDIOVASCULAR DISORDERS AND LOWERING RISK OF CARDIOVASCULAR EVENTS
#198Hepatitis B antiviral agents
#199OINTMENT CONTAINING AN OXAZOLE COMPOUND
#200Heterocyclic compound
#201Compositions and methods of treating cardiac fibrosis with ifetroban
#202ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE
#203COMPOSITIONS FOR MODULATING PD-1 SIGNAL TRANSDUCTION
#204PPAR GAMMA MODULATORS FOR TREATING CYSTIC DISEASES
#205OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION
#206Pharmaceutical combination comprising ponesimod
#207Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
#208AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS
#209Compounds and methods for inhibiting phosphate transport
#210Isoxazoline-substituted benzamide compound and pesticide
#211Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
#212Hybrid telodendrimers
#213Pharmaceutical compounds
#214Compositions and methods for treating severe pain
#215IL-8 INHIBITORS FOR USE IN THE TREATMENT OF SOME UROLOGICAL DISORDERS
#216Autophagy enhancer and use thereof
#217ACTIVATORS OF HIV LATENCY
#218Prodrugs of Chlorokynurenines
#219GP130 modulators
#220Neprilysin inhibitors
#221Fatty acids as anti-inflammatory agents
#222Triazole furan compounds as agonists of the APJ receptor
#223(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
#224WOUND-HEALING AGENT
#225Oxazolidinone compounds and methods of use thereof as antibacterial agents
#226Compositions and methods of treating cardiac fibrosis with ifetroban
#227TREATMENT OF FIBROTIC DISORDERS WITH JUN N-TERMINAL KINASE INHIBITORS
#228REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#229Nrf2 regulators
#230Use of a combination of Adelmidrol and hyaluronic acid in the treatment of pain caused by osteoarthritis and epithelial dysfunctions
#231TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT
#232Modulators of the integrated stress pathway
#233PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#234MUTATED FIBROBLAST GROWTH FACTOR (FGF) 1 AND METHODS OF USE
#235Compounds For The Treatment Of Neuromuscular Disorders
#236Inhibition of sphingosine 1-phosphate receptor for treatment and prevention of lymphedema
#237FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF
#238Therapeutic combinations to treat red blood cell disorders
#239FORMULATION OF METAXALONE
#240Metallo-beta-lactamase inhibitors
#241NOVEL TRAPS IN THE TREATMENT OF MACULAR DEGENERATION
#242Heterocyclic compound
#243Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
#244ANALOGS OF CYP-EICOSANOIDS FOR USE IN TREATING OR PREVENTING A DISORDER ASSOCIATED WITH NEOVASCULARIZATION AND/OR INFLAMMATION
#245Use of pharmaceutical composition for the treatment of skin erythema in poikilodermas
#246Analgesic compounds
#247Compounds for treatment of cancer
#248FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA
#249Hepatitis B antiviral agents
#250Lysosomal acid lipase and PPAR gamma ligands as immune therapies for cancer treatment
#251FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA
#252OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION
#253Chemotherapeutic Methods
#254Hepatitis B antiviral agents
#255NOVEL CLASS OF COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE
#256Aminoazole derivative
#257Reprogramming-based models of neurodevelopmental disorders and uses thereof
#258IDO inhibitors
#259Ointment containing an oxazole compound
#260PPAR-alpha agonist treatment of neuropsychiatric disorders
#261Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same
#262Compositions and methods of treating cardiac fibrosis with ifetroban
#263SOLID PHARMACEUTICAL DOSAGE FORM FOR RELEASE OF AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT IN THE ORAL CAVITY
#264PRODRUGS OF CHLOROKYNURENINES
#265Methods of treating muscular dystrophy
#266Isoxazoline-substituted benzamide compound and pesticide
#267OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS
#268Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors
#269Farnesoid X receptor agonists and uses thereof
#270Inhibitors of the plasmodial surface anion channel as antimalarials
#271THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE
#272Methods of treating muscular dystrophy
#273SINGLE SOLID ORAL DOSAGE FORMS FOR TREATING HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE
#274Novel formulation of metaxalone
#275Metallo-beta-lactamase inhibitors
#276Neprilysin inhibitors
#277Heterocyclic compound
#278Pancreatitis treatment
#279(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
#280Substituted oxazoles for the treatment of cancer
#281Anticancer agent comprising aminoacetonitrile compound as active ingredient
#282METHODS OF TREATING NEURODEGENERATIVE DISEASES USING INDANE ACETIC ACID DERIVATIVES WHICH PENETRATE THE BLOOD BRAIN BARRIER
#283MUTATED FIBROBLAST GROWTH FACTOR (FGF) 1 AND METHODS OF USE
#284NEPRILYSIN INHIBITORS
#285Metallo-β-lactamase inhibitors
#286HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
#287ROR gamma (RORγ) modulators
#288PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#289NRF2 regulators
#290Method for improving the dissolution profile of a biologically active material
#291COMPOSITIONS FOR MODULATING PD-1 SIGNAL TRANSDUCTION
#292METHOD OF TREATING ATHEROSCLEROSIS IN HIGH TRIGLYCERIDE SUBJECTS
#293METHODS OF DOSE ADMINISTRATION FOR TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES
#294METHODS OF TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES BASED ON APOE4 GENOTYPE
#295FORMULATION OF METAXALONE
#296AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES
#297Compounds and methods for the treatment of neurodegenerative diseases
#298Targeting metabolic adaptive responses to chemotherapy
#299METHODS OF TREATING LIVER DISEASE USING INDANE ACETIC ACID DERIVATIVES
#300Monocyclic compound